The Evolving Approach of Presenting Risk Information to Consumers

Posted 25 September 2015 By Richard Lem, PharmD

placeholder+image This article discusses an evolving approach to present prescription drug risk information to consumers based on recent guidances released by the Agency.

Share this article:

Categories: Drugs, Medical Devices, Compliance, Government affairs, Features, US, FDA, Advertising and Promotion

Tags: Office of Prescription Drug Promotion, FDA, draft guidance, social media, drug ads on social media

Regulatory Exchange: Latest Updates From the Community